Activ Surgical, a Boston, MA-based digital surgery company, raised $45m in Series B financing.
The round was led by Cota Capital, a multi-stage investment firm focused on private and public modern enterprise technology companies, with participation from BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision and NVIDIA. They joined existing investors DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV) and ARTIS Ventures. In conjunction with this fundraise, the Activ Surgical Board of Directors will expand to include Bobby Yazdani, founder and partner from Cota Capital.
The company, which has raised a total of $77 in total funding to date, intends to use the funds:
- to expand the commercial availability of the ActivInsights software suite, including the first Insight–an AR-based overlay that displays tissue perfusion in real time without the use of traditional dyes,
- to extend its commercialization efforts in the U.S.,
- to pursue a CE mark in support of the global rollout,
- to further enhance the ActivInsights software platform, and
- to develop its first ML-based insights.
Led by Todd Usen, CEO, Activ Surgical is a digital surgery company that completed the world’s first autonomous robotic surgery of soft tissue in 2018. The company is building a hardware-agnostic platform, including the recently announced ActivInsights™ augmented reality (AR)-based software suite, to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence (AI), machine learning (ML), AR and robotics. Its patent-protected surgical software platform–ActiveEdge™–is being designed to reduce unintended and preventable surgical errors by enhancing a surgeon’s intraoperative decision-making via the aggregation of surgical data from around the world.
FinSMEs
30/09/2021